1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions ISO RGD:3949 6480464 2, 2'-hydroxynitrosohydrazonobis-ethanamine inhibits the reaction [lead acetate affects the localization of VAMP2 protein] CTD PMID:22265330 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of VAMP2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of VAMP2 mRNA CTD PMID:17555576 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:3949 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:3949 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of VAMP2 mRNA] CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VAMP2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of VAMP2 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735448 6480464 Tetrachlorodibenzodioxin affects the expression of VAMP2 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:3949 6480464 Tetrachlorodibenzodioxin results in decreased expression of VAMP2 mRNA CTD PMID:21215274 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of VAMP2 mRNA CTD PMID:20188158 3H-1,2-dithiole-3-thione increases expression ISO RGD:3949 6480464 1, 2-dithiol-3-thione results in increased expression of VAMP2 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of VAMP2 mRNA CTD PMID:18648102 ammonium chloride affects expression ISO RGD:3949 6480464 Ammonium Chloride affects the expression of VAMP2 mRNA CTD PMID:16483693 benzo[a]pyrene multiple interactions EXP 6480464 Benzoapyrene promotes the reaction [AHR protein binds to VAMP2 promoter] CTD PMID:19654925 benzo[a]pyrene affects methylation ISO RGD:735448 6480464 Benzoapyrene affects the methylation of VAMP2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of VAMP2 mRNA CTD PMID:22228805 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:735448 6480464 Diethylhexyl Phthalate results in decreased expression of VAMP2 protein CTD PMID:31163220 bisphenol A increases expression ISO RGD:3949 6480464 bisphenol A results in increased expression of VAMP2 mRNA, bisphenol A results in increased expression of VAMP2 protein CTD PMID:25181051 , PMID:28739533 buta-1,3-diene decreases expression EXP 6480464 1, 3-butadiene results in decreased expression of VAMP2 mRNA CTD PMID:29038090 C60 fullerene increases expression ISO RGD:3949 6480464 fullerene C60 results in increased expression of VAMP2 mRNA CTD PMID:19167457 capsaicin decreases expression ISO RGD:3949 6480464 Capsaicin results in decreased expression of VAMP2 mRNA CTD PMID:20349343 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 cisplatin increases expression ISO RGD:735448 6480464 Cisplatin results in increased expression of VAMP2 mRNA CTD PMID:27392435 clozapine increases expression ISO RGD:3949 6480464 Clozapine results in increased expression of VAMP2 mRNA CTD PMID:15860345 cobalt dichloride decreases expression ISO RGD:735448 6480464 cobaltous chloride results in decreased expression of VAMP2 mRNA CTD PMID:19320972 , PMID:19376846 D-gluconic acid multiple interactions ISO RGD:3949 6480464 [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of VAMP2 mRNA CTD PMID:16556975 decabromodiphenyl ether decreases expression ISO RGD:3949 6480464 decabromobiphenyl ether results in decreased expression of VAMP2 mRNA, decabromobiphenyl ether results in decreased expression of VAMP2 protein CTD PMID:28104350 deoxycholic acid multiple interactions ISO RGD:3949 6480464 [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of VAMP2 mRNA CTD PMID:16556975 dexamethasone increases expression ISO RGD:3949 6480464 Dexamethasone results in increased expression of VAMP2 mRNA CTD PMID:31518422 diazinon increases methylation ISO RGD:735448 6480464 Diazinon results in increased methylation of VAMP2 gene CTD PMID:22964155 dibutyl phthalate decreases expression ISO RGD:3949 6480464 Dibutyl Phthalate results in decreased expression of VAMP2 mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:735448 6480464 dicrotophos results in increased expression of VAMP2 mRNA CTD PMID:28302478 doxorubicin decreases expression ISO RGD:735448 6480464 Doxorubicin results in decreased expression of VAMP2 mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:3949 6480464 Endosulfan results in increased expression of VAMP2 mRNA CTD PMID:29391264 ethanol increases expression ISO RGD:3949 6480464 Ethanol results in increased expression of VAMP2 mRNA CTD PMID:20655511 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of VAMP2 mRNA CTD PMID:30319688 gamma-tocopherol increases expression EXP 6480464 Tocopherols results in increased expression of VAMP2 mRNA CTD PMID:17654050 haloperidol decreases expression ISO RGD:3949 6480464 Haloperidol results in decreased expression of VAMP2 mRNA CTD PMID:15860345 haloperidol increases expression ISO RGD:3949 6480464 Haloperidol results in increased expression of VAMP2 mRNA CTD PMID:15860345 hydrazines increases expression EXP 6480464 Hydrazines results in increased expression of VAMP2 mRNA CTD PMID:21647536 hypochlorous acid decreases expression EXP 6480464 Hypochlorous Acid results in decreased expression of VAMP2 mRNA CTD PMID:19376150 lead diacetate multiple interactions ISO RGD:3949 6480464 2 more ... CTD PMID:20375082 , PMID:22265330 lead diacetate affects expression ISO RGD:3949 6480464 lead acetate affects the expression of VAMP2 mRNA CTD PMID:27984133 lead diacetate affects localization ISO RGD:3949 6480464 lead acetate affects the localization of VAMP2 protein CTD PMID:22265330 lead diacetate decreases expression ISO RGD:3949 6480464 lead acetate results in decreased expression of VAMP2 protein CTD PMID:20375082 lead(0) affects expression ISO RGD:735448 6480464 Lead affects the expression of VAMP2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:735448 6480464 Lead affects the expression of VAMP2 mRNA CTD PMID:28903495 leflunomide increases expression ISO RGD:735448 6480464 leflunomide results in increased expression of VAMP2 mRNA CTD PMID:28988120 methylparaben increases expression ISO RGD:735448 6480464 methylparaben results in increased expression of VAMP2 mRNA CTD PMID:31745603 nicotinamide multiple interactions ISO RGD:3949 6480464 [Streptozocin co-treated with Niacinamide] results in decreased expression of VAMP2 mRNA, resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of VAMP2 mRNA] CTD PMID:25999625 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of VAMP2 mRNA CTD PMID:17562736 paraquat increases expression ISO RGD:3949 6480464 Paraquat results in increased expression of VAMP2 mRNA CTD PMID:18198484 PCB138 decreases expression ISO RGD:3949 6480464 2 more ... CTD PMID:23829299 pirinixic acid multiple interactions EXP 6480464 NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of VAMP2 mRNA], PPARA protein promotes the reaction [pirinixic acid results in decreased expression of VAMP2 mRNA] CTD PMID:17950772 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of VAMP2 mRNA CTD PMID:17950772 pirinixic acid multiple interactions ISO RGD:735448 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of VAMP2 mRNA CTD PMID:19710929 pravastatin multiple interactions EXP 6480464 [LDLR gene mutant form results in increased susceptibility to Pravastatin] which results in decreased expression of VAMP2 protein CTD PMID:26875785 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of VAMP2 mRNA CTD PMID:21278054 resveratrol multiple interactions ISO RGD:3949 6480464 resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of VAMP2 mRNA] CTD PMID:25999625 streptozocin multiple interactions ISO RGD:3949 6480464 [Streptozocin co-treated with Niacinamide] results in decreased expression of VAMP2 mRNA, resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of VAMP2 mRNA] CTD PMID:25999625 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of VAMP2 mRNA CTD PMID:17555576 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of VAMP2 mRNA CTD PMID:17484886 tetraphene increases expression EXP 6480464 benzaanthracene results in increased expression of VAMP2 mRNA CTD PMID:26377693 thioacetamide decreases expression ISO RGD:3949 6480464 Thioacetamide results in decreased expression of VAMP2 mRNA CTD PMID:23411599 tocopherol increases expression EXP 6480464 Tocopherols results in increased expression of VAMP2 mRNA CTD PMID:17654050 trimethylamine N-oxide multiple interactions ISO RGD:3949 6480464 trimethyloxamine promotes the reaction [rimabotulinumtoxinB results in increased cleavage of VAMP2 protein modified form] CTD PMID:27032463 urethane increases expression ISO RGD:735448 6480464 Urethane results in increased expression of VAMP2 mRNA CTD PMID:28818685 vinclozolin decreases expression ISO RGD:3949 6480464 vinclozolin results in decreased expression of VAMP2 mRNA CTD PMID:20566332 vincristine decreases expression ISO RGD:735448 6480464 Vincristine results in decreased expression of VAMP2 mRNA CTD PMID:23649840 zoledronic acid increases expression ISO RGD:735448 6480464 zoledronic acid results in increased expression of VAMP2 protein CTD PMID:28871336